It also said it had concluded phase 3 trials using oral semaglutide in people to treat obesity
10.2337/dc15-2298 11
During the neuroinflammatory process, microglia get over-activated and oversensitive, and they can trigger the release of several cytotoxic molecules like tumor necrosis factor (TNF), pro-inflammatory cytokines (e.g., IL-1, IL-6, IL-18), and interferon- (IFN-), and oxidative metabolites (e.g., reactive nitrogen and oxygen species, and nitric oxide) [13]
Discontinuation because of gastrointestinal events was more frequent with semaglutide (10.0% vs
387 Notably, the CKD-FIX study and the PERL trials demonstrated that allopurinol did not significantly slow the deterioration of estimated glomerular filtration rate (eGFR) in chronic kidney disease patients compared to placebo, over a span of 2 and 3 years, respectively